Chang SS. Re: Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine plus Cisplatin in Patients with Muscle-Invasive Bladder Cancer. J Urol 2020 Jan 13:101097JU0000000000000729. doi: 10.1097/JU.0000000000000729.
PMID: 31928467